1)Adams KF Jr, et al:Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 39:946-953, 2002
2)Ahmed A, et al:Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure:A propensity-matched study of the DIG trial. Int J Cardiol 123:138-146, 2008
3)Yabek SM, et al:Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol 8:197-207, 1986
4)志賀 剛,他:致死的不整脈に対する低用量のアミオダロン長期治療とその効果 自験例による検討.Prog Med 22(Suppl 1):566-570, 2002
5)Tsuchishita Y, et al:Relationship between serum cibenzoline concentrations and hypoglycemia. Jpn J Ther Drug Monit 20:331-337, 2003
6)木村利美(編著):図解 よくわかるTDM 第2版,p180-181,じほう,2007